Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies

Nature Chemical Biology

Volumn 9, Issue 8, 2013, Pages 521-526

  Amin, Mohammed N ^a   Mclellan, Jason S ^b   Huang, Wei ^a   Orwenyo, Jared ^a   Burton, Dennis R ^c,d   Koff, Wayne C ^e   Kwong, Peter D ^b   Wang, Lai Xi ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOPEPTIDE; GLYCOPROTEIN GP 120; NEUTRALIZING ANTIBODY;

ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME SYNTHESIS; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SIALYLATION;

AIDS VACCINES; ANTIBODIES, NEUTRALIZING; EPITOPES; GLYCOPEPTIDES; HIV-1; POLYSACCHARIDES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84880923748     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1288     Document Type: Article

References (42)

1. Burton, D.R. et al. A blueprint for HIV vaccine discovery. Cell Host Microbe 12, 396-407 (2012
2. Kwong, P.D., Mascola, J.R. & Nabel, G.J. Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1. Cold Spring Harb. Perspect. Med. 1, a007278 (2011
3. Walker, L.M. & Burton, D.R. Rational antibody-based HIV-1 vaccine design: Current approaches and future directions. Curr. Opin. Immunol. 22, 358-366 (2010
4. Zolla-Pazner, S. Identifying epitopes of HIV-1 that induce protective antibodies. Nat. Rev. Immunol. 4, 199-210 (2004
5. Reitter, J.N., Means, R.E. & Desrosiers, R.C. A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4, 679-684 (1998
6. Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307-312 (2003
7. Trkola, A. et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70, 1100-1108 (1996
8. Calarese, D.A. et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300, 2065-2071 (2003
9. Walker, L.M. et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326, 285-289 (2009
10. Doores, K.J. & Burton, D.R. Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16. J. Virol. 84, 10510-10521 (2010
11. Bonsignori, M. et al. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J. Virol. 85, 9998-10009 (2011
12. Walker, L.M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466-470 (2011
13. McLellan, J.S. et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480, 336-343 (2011
14. Pejchal, R. et al. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334, 1097-1103 (2011
15. Leonard, C.K. et al. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265, 10373-10382 (1990
16. Zhu, X., Borchers, C., Bienstock, R.J. & Tomer, K.B. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39, 11194-11204 (2000
17. Go, E.P. et al. Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility. J. Proteome Res. 7, 1660-1674 (2008
18. Gamblin, D.P., Scanlan, E.M. & Davis, B.G. Glycoprotein synthesis: An update. Chem. Rev. 109, 131-163 (2009
19. Schmaltz, R.M., Hanson, S.R. & Wong, C.H. Enzymes in the synthesis of glycoconjugates. Chem. Rev. 111, 4259-4307 (2011
20. Wang, L.X. Chemoenzymatic synthesis of glycopeptides and glycoproteins through endoglycosidase-catalyzed transglycosylation. Carbohydr. Res. 343, 1509-1522 (2008
21. Wang, L.X. & Lomino, J.V. Emerging technologies for making glycan-defined glycoproteins. ACS Chem. Biol. 7, 110-122 (2012
22. Li, H. et al. Chemoenzymatic synthesis of HIV-1 V3 glycopeptides carrying two N-glycans and effects of glycosylation on the peptide domain. J. Org. Chem. 70, 9990-9996 (2005
23. Li, B., Zeng, Y., Hauser, S., Song, H. & Wang, L.X. Highly efficient endoglycosidase-catalyzed synthesis of glycopeptides using oligosaccharide oxazolines as donor substrates. J. Am. Chem. Soc. 127, 9692-9693 (2005
24. Ochiai, H., Huang, W. & Wang, L.X. Expeditious chemoenzymatic synthesis of homogeneous N-glycoproteins carrying defined oligosaccharide ligands. J. Am. Chem. Soc. 130, 13790-13803 (2008
25. Umekawa, M. et al. Mutants of Mucor hiemalis endo-β-N- acetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities. J. Biol. Chem. 283, 4469-4479 (2008
26. Huang, W. et al. Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans. J. Am. Chem. Soc. 131, 2214-2223 (2009
27. Huang, W., Zhang, X., Ju, T., Cummings, R.D. & Wang, L.X. Expeditious chemoenzymatic synthesis of CD52 glycopeptide antigens. Org. Biomol. Chem. 8, 5224-5233 (2010
28. Umekawa, M. et al. Efficient glycosynthase mutant derived from Mucor hiemalis endo-β-N-acetylglucosaminidase capable of transferring oligosaccharide from both sugar oxazoline and natural N-glycan. J. Biol. Chem. 285, 511-521 (2010
29. Schwarz, F. et al. A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation. Nat. Chem. Biol. 6, 264-266 (2010
30. Zou, G. et al. Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor. J. Am. Chem. Soc. 133, 18975-18991 (2011
31. Amin, M.N., Huang, W., Mizanur, R.M. & Wang, L.X. Convergent synthesis of homogeneous Glc1Man9GlcNAc2-protein and derivatives as ligands of molecular chaperones in protein quality control. J. Am. Chem. Soc. 133, 14404-14417 (2011
32. Fan, S.Q., Huang, W. & Wang, L.X. Remarkable transglycosylation activity of glycosynthase mutants of Endo-D, an endo-β-N- acetylglucosaminidase from Streptococcus pneumoniae. J. Biol. Chem. 287, 11272-11281 (2012
33. Huang, W., Giddens, J., Fan, S.Q., Toonstra, C. & Wang, L.X. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions. J. Am. Chem. Soc. 134, 12308-12318 (2012
34. Lal, A. et al. Substrate specificities of recombinant murine Golgi α1, 2-mannosidases IA and IB and comparison with endoplasmic reticulum and Golgi processing α1,2-mannosidases. Glycobiology 8, 981-995 (1998
35. Noguchi, M., Tanaka, T., Gyakushi, H., Kobayashi, A. & Shoda, S.I. Efficient synthesis of sugar oxazolines from unprotected N-acetyl-2-amino sugars by using chloroformamidinium reagent in water. J. Org. Chem. 74, 2210-2212 (2009
36. Huang, W., Yang, Q., Umekawa, M., Yamamoto, K & Wang, L.X. Arthrobacter endo-β-N-acetylglucosaminidase shows transglycosylation activity on complex-type N-glycan oxazolines: One-pot conversion of ribonuclease B to sialylated ribonuclease C. ChemBioChem 11, 1350-1355 (2010
37. Huang, W., Ochiai, H., Zhang, X. & Wang, L.X. Introducing N-glycans into natural products through a chemoenzymatic approach. Carbohydr. Res. 343, 2903-2913 (2008
38. Spiro, R.G. Protein glycosylation: Nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12, 43R-56R (2002
39. Pancera, M. et al. Structural basis for diverse N-glycan recognition and enhanced HIV-1 neutralization by V1/V2-directed antibodies. Nat. Struct. Mol. Biol. http://dx.doi.org/10.1038/nsmb.2600 (2013
40. Mouquet, H. et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc. Natl. Acad. Sci. USA 109, E3268-E3277 (2012
41. Bachmann, M.F. & Jennings, G.T. Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787-796 (2010
42. Julien, J.P. et al. Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. Proc. Natl. Acad. Sci. USA 110, 4351-4356 (2013